Timing and cause of death
Variable . | Steroids + placebo; n = 49 (%) . | Steroids + daclizumab; n = 53 (%) . |
|---|---|---|
| Currently alive, no. (%) | 31 (63) | 18 (34) |
| Timing of death, no. (%) | ||
| Within 100 d of transplantation | 3 (6) | 12 (23) |
| 100 d to 1 y after transplantation | 13 (27) | 22 (42) |
| More than 1 y after transplantation | 2 (4) | 1 (2) |
| Cause of death, no. (%) | ||
| Disease related | 4 (8) | 14 (26) |
| GVHD related | 5 (10) | 15 (28) |
| Not due to disease or GVHD | 9 (18) | 6 (11) |
Variable . | Steroids + placebo; n = 49 (%) . | Steroids + daclizumab; n = 53 (%) . |
|---|---|---|
| Currently alive, no. (%) | 31 (63) | 18 (34) |
| Timing of death, no. (%) | ||
| Within 100 d of transplantation | 3 (6) | 12 (23) |
| 100 d to 1 y after transplantation | 13 (27) | 22 (42) |
| More than 1 y after transplantation | 2 (4) | 1 (2) |
| Cause of death, no. (%) | ||
| Disease related | 4 (8) | 14 (26) |
| GVHD related | 5 (10) | 15 (28) |
| Not due to disease or GVHD | 9 (18) | 6 (11) |